BNP Paribas Financial Markets Grows Stock Holdings in Utah Medical Products, Inc. (NASDAQ:UTMD)

BNP Paribas Financial Markets increased its holdings in shares of Utah Medical Products, Inc. (NASDAQ:UTMD) by 102.7% in the 3rd quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 1,117 shares of the medical instruments supplier’s stock after purchasing an additional 566 shares during the period. BNP Paribas Financial Markets’ holdings in Utah Medical Products were worth $75,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Several other institutional investors have also recently made changes to their positions in the business. Bard Associates Inc. raised its position in Utah Medical Products by 1.1% during the third quarter. Bard Associates Inc. now owns 19,781 shares of the medical instruments supplier’s stock valued at $1,329,000 after acquiring an additional 224 shares in the last quarter. Copeland Capital Management LLC acquired a new stake in shares of Utah Medical Products during the 3rd quarter worth approximately $53,000. Rhumbline Advisers grew its stake in shares of Utah Medical Products by 17.3% during the 2nd quarter. Rhumbline Advisers now owns 5,508 shares of the medical instruments supplier’s stock worth $368,000 after purchasing an additional 812 shares during the period. Allspring Global Investments Holdings LLC purchased a new position in shares of Utah Medical Products during the 2nd quarter valued at approximately $83,000. Finally, Bank of New York Mellon Corp lifted its stake in shares of Utah Medical Products by 2.9% in the 2nd quarter. Bank of New York Mellon Corp now owns 49,604 shares of the medical instruments supplier’s stock valued at $3,314,000 after purchasing an additional 1,391 shares during the period. Hedge funds and other institutional investors own 69.60% of the company’s stock.

Analysts Set New Price Targets

Separately, StockNews.com lowered shares of Utah Medical Products from a “strong-buy” rating to a “buy” rating in a research report on Thursday, November 7th.

Utah Medical Products Stock Up 0.1 %

Shares of Utah Medical Products stock opened at $62.08 on Friday. The firm has a market cap of $210.58 million, a PE ratio of 14.54 and a beta of 0.08. Utah Medical Products, Inc. has a twelve month low of $61.48 and a twelve month high of $87.00. The business has a 50-day moving average price of $64.99 and a 200 day moving average price of $66.64.

Utah Medical Products Increases Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Friday, January 3rd. Stockholders of record on Monday, December 16th will be given a $0.305 dividend. The ex-dividend date is Monday, December 16th. This is a boost from Utah Medical Products’s previous quarterly dividend of $0.30. This represents a $1.22 dividend on an annualized basis and a dividend yield of 1.97%. Utah Medical Products’s payout ratio is 28.57%.

Utah Medical Products Company Profile

Utah Medical Products, Inc develops, manufactures, and distributes medical devices for the healthcare industry worldwide. It offers fetal monitoring accessories, vacuum-assisted delivery systems, and other labor and delivery tools; DISPOSA-HOOD infant respiratory hoods; and DELTRAN PLUS blood pressure monitoring systems.